The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: A multicentre, randomised controlled trial

Thorax

Volumn 69, Issue 2, 2014, Pages 137-143

  Osadnik, Christian R ^a,b   McDonald, Christine F ^b   Miller, Belinda R ^c   Hill, Catherine J ^b   Tarrant, Ben ^c   Steward, Ranjana ^c   Chao, Caroline ^b   Stodden, Nicole ^b   Oliveira, Cristino C ^a   Gagliardi, Nadia ^b   Holland, Anne E ^a,b,c  

^a LA TROBE UNIVERSITY   (Australia)

^b AUSTIN HEALTH   (Australia)

^c Alfred Health ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; OXYGEN;

AGED; AIRWAY OBSTRUCTION; ARTICLE; BODE INDEX; BODY MASS; BREATHLESSNESS COUGH AND SPUTUM SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DYSPNEA; EXERCISE; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASK; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONINVASIVE VENTILATION; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOM; TREATMENT OUTCOME;

COPD EXACERBATIONS; EXERCISE;

ACUTE DISEASE; AGED; COMBINED MODALITY THERAPY; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; POSITIVE-PRESSURE RESPIRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX; SPUTUM; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892509681     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203425     Document Type: Article

References (33)

1. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57: 847-52. (Pubitemid 35178607)
2. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001;164: 358-64. (Pubitemid 32778199)
3. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157(5 Pt 1): 1418-22.
4. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356: 775-89. (Pubitemid 46294610)
5. Hurst JR, Donaldson GC, Quint JK, et al. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179: 369-74.
6. Osadnik C, Stuart-Andrews C, Ellis S, et al. Positive expiratory pressure via mask does not improve ventilation inhomogeneity more than huffing and coughing in individuals with stable chronic obstructive pulmonary disease and chronic sputum expectoration. Respiration. Published Online First: 8 June 2013. doi: 10.1159/000348546
7. Osadnik CR, McDonald CF, Holland AE. Airway clearance techniques in acute exacerbations of COPD: a survey of Australian physiotherapy practice. Physiotherapy 2013;99: 101-6.
8. Osadnik CR, McDonald CF, Jones AP, et al. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;(3):CD008328.
9. Bellone A, Spagnolatti L, Massobrio M, et al. Short-term effects of expiration under positive pressure in patients with acute exacerbation of chronic obstructive pulmonary disease and mild acidosis requiring non-invasive positive pressure ventilation. Intensive Care Medicine 2002;28: 581-5. (Pubitemid 34594589)
10. Vargas F, Bui HN, Boyer A, et al. Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial [with consumer summary]. Crit Care 2005;9:R382-9.
11. National Institute for Health and Clinical Excellence (NICE). Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care 2010 Jun. http://www.nice.org. uk/CG101 (accessed 15 Nov 2012).
12. Miravitlles M, Anzueto A, Legnani D, et al. Patient's perception of exacerbations of COPD - the PERCEIVE study. Respir Med 2007;101: 453-60. (Pubitemid 46196335)
13. McKenzie DK, Abramson M, Crockett AJ, et al. The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease V2.30, 2011 2011. http://www.copdx.org.au/(accessed 15 Nov 2012).
14. Holland AE, Button BM. Is there a role for airway clearance techniques in chronic obstructive pulmonary disease? Chron Respir Dis 2006;3: 83-91. (Pubitemid 43774257)
15. Leidy NK, Rennard SI, Schmier J, et al. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest 2003;124: 2182-91. (Pubitemid 38010588)
16. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B): 25-31; discussion 3-7.
17. Fletcher CM, Elmes PC, Fairbairn AS, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ 1959;2: 257-66.
18. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350: 1005-12. (Pubitemid 38269277)
19. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007;131: 696-704. (Pubitemid 46446859)
20. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. 2nd edn. New Jersey, USA: John Wiley & Sons, Inc., 2011.
21. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106: 196-204. (Pubitemid 17009877)
22. Cross J, Elender F, Barton G, et al. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX). Health Technol Assess 2010;14: 1-147, iii-iv.
23. de Torres JP, Pinto-Plata V, Ingenito E, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002;121: 1092-8. (Pubitemid 34280427)
24. Puhan MA, Mador MJ, Held U, et al. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008;32: 637-43.
25. Holland AE, Hill CJ, Rasekaba T, et al. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010;91: 221-5.
26. van der Schans CP, Postma DS, Koeter GH, et al. Physiotherapy and bronchial mucus transport. Eur Respir J 1999;13: 1477-86. (Pubitemid 29357169)
27. Kodric M, Garuti G, Colomban M, et al. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations. Respirology 2009;14: 424-8.
28. Geelhoed EA, Brameld KJ, Holman CD, etal. Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends. Intern Med J 2007;37: 87-94. (Pubitemid 46066617)
29. Harth L, Stuart J, Montgomery C, etal. Physical therapy practice patterns in acute exacerbations of chronic obstructive pulmonary disease. Can Respir J 2009;16: 86-92.
30. Lee A, Button B, Denehy L. Current Australian and New Zealand physiotherapy practice in the management of patients with bronchiectasis and chronic obstructive pulmonary disease. N Z J Physiother 2008;36: 49-58.
31. Yohannes AM, Connolly MJ. A national survey: percussion, vibration, shaking and active cycle breathing techniques used in patients with acute exacerbations of chronic obstructive pulmonary disease. Physiotherapy 2007;93: 110-13. (Pubitemid 47497366)
32. Cochrane GM, Webber BA, Clarke SW. Effects of sputum on pulmonary function. BMJ 1977;2: 1181-3. (Pubitemid 8215606)
33. Graham WG, Bradley DA. Efficacy of chest physiotherapy and intermittent positive-pressure breathing in the resolution of pneumonia. N Engl J Med 1978;299: 624-7. (Pubitemid 9022104)